Skip to main content

Carbonic anhydrase IX overexpression regulates the migration and progression in oral squamous cell carcinoma

Tumor Biology volume 36, pages 9517–9524 (2015)Cite this article

Abstract

Carbonic anhydrase IX (CAIX) is reportedly overexpressed in several types of carcinomas and is generally considered a marker of malignancy. The current study investigated the association between membrane expression of CAIX and the clinicopathological characteristics in oral squamous cell carcinoma (OSCC) patients. The study used immunohistochemistry to examine CAIX expression in 271 OSCC specimens by tissue microarray (TMA) and assessed the effect of CAIX overexpression and knockdown on migration of oral cancer cells in vitro. We found that CAIX expression was associated with more advanced clinical stages (p = 0.030) and positive lymph node metastasis (p = 0.026). Importantly, CAIX expression was correlated with a poorer patient prognosis in a univariate survival analysis (p = 0.025). Moreover, CAIX suppression by small interfering RNA (siRNA) significantly reduced cellular migration in OECM-1 oral cancer cell. In conclusion, our study showed that the expression of CAIX in OSCC samples can predict the progression of OSCC and survival of OSCC patients in Taiwan.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.

    Article  PubMed  Google Scholar 

  2. Cunderlikova B, Vasovic V, Randeberg LL, Christensen E, Warloe T, Nesland JM, Peng Q. Modification of extracorporeal photopheresis technology with porphyrin precursors. Comparison between 8-methoxypsoralen and hexaminolevulinate in killing human T-cell lymphoma cell lines in vitro. Biochim Biophys Acta. 2014

  3. Johnson NW, Warnakulasuriya S, Gupta PC, Dimba E, Chindia M, Otoh EC, et al. Global oral health inequalities in incidence and outcomes for oral cancer: causes and solutions. Adv Dent Res. 2011;23:237–46.

    CAS  Article  PubMed  Google Scholar 

  4. Bagan J, Sarrion G, Jimenez Y. Oral cancer: clinical features. Oral Oncol. 2010;46:414–7.

    Article  PubMed  Google Scholar 

  5. Chang SW, Kareem SA, Kallarakkal TG, Merican AF, Abraham MT, Zain RB. Feature selection methods for optimizing clinicopathologic input variables in oral cancer prognosis. Asian Pac J Cancer Prev APJCP. 2011;12:2659–64.

    PubMed  Google Scholar 

  6. Wu JY, Yi C, Chung HR, Wang DJ, Chang WC, Lee SY, et al. Potential biomarkers in saliva for oral squamous cell carcinoma. Oral Oncol. 2010;46:226–31.

    CAS  Article  PubMed  Google Scholar 

  7. Noguti J, De Moura CF, De Jesus GP, Da Silva VH, Hossaka TA, Oshima CT, et al. Metastasis from oral cancer: an overview. Cancer Genom Proteom. 2012;9:329–35.

    CAS  Google Scholar 

  8. Ruan K, Song G, Ouyang G. Role of hypoxia in the hallmarks of human cancer. J Cell Biochem. 2009;107:1053–62.

    CAS  Article  PubMed  Google Scholar 

  9. Pastorekova S, Zatovicova M, Pastorek J. Cancer-associated carbonic anhydrases and their inhibition. Curr Pharm Des. 2008;14:685–98.

    CAS  Article  PubMed  Google Scholar 

  10. Supuran CT. Carbonic anhydrases—an overview. Curr Pharm Des. 2008;14:603–14.

    CAS  Article  PubMed  Google Scholar 

  11. Fang JS, Gillies RD, Gatenby RA. Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression. Semin Cancer Biol. 2008;18:330–7.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  12. Beketic-Oreskovic L, Ozretic P, Rabbani ZN, Jackson IL, Sarcevic B, Levanat S, et al. Prognostic significance of carbonic anhydrase IX (CA-IX), endoglin (CD105) and 8-hydroxy-2’-deoxyguanosine (8-OHdG) in breast cancer patients. Pathol Oncol Res POR. 2011;17:593–603.

    CAS  Article  PubMed  Google Scholar 

  13. Liao SY, Aurelio ON, Jan K, Zavada J, Stanbridge EJ. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney. Cancer Res. 1997;57:2827–31.

    CAS  PubMed  Google Scholar 

  14. Korkeila E, Talvinen K, Jaakkola PM, Minn H, Syrjanen K, Sundstrom J, et al. Expression of carbonic anhydrase IX suggests poor outcome in rectal cancer. Br J Cancer. 2009;100:874–80.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  15. Choschzick M, Oosterwijk E, Muller V, Woelber L, Simon R, Moch H, et al. Overexpression of carbonic anhydrase IX (CAIX) is an independent unfavorable prognostic marker in endometrioid ovarian cancer. Virchows Archiv Int J Pathol. 2011;459:193–200.

    CAS  Article  Google Scholar 

  16. Birner P, Jesch B, Friedrich J, Riegler M, Zacherl J, Hejna M, et al. Carbonic anhydrase IX overexpression is associated with diminished prognosis in esophageal cancer and correlates with Her-2 expression. Ann Surg Oncol. 2011;18:3330–7.

    Article  PubMed  Google Scholar 

  17. Choschzick M, Woelber L, Hess S, zu Eulenburg C, Schwarz J, Simon R, et al. Overexpression of carbonic anhydrase IX (CAIX) in vulvar cancer is associated with tumor progression and development of locoregional lymph node metastases. Virchows Archiv Int J Pathol. 2010;456:483–90.

    CAS  Article  Google Scholar 

  18. Woelber L, Kress K, Kersten JF, Choschzick M, Kilic E, Herwig U, et al. Carbonic anhydrase IX in tumor tissue and sera of patients with primary cervical cancer. BMC Cancer. 2011;11:12.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Hynninen P, Parkkila S, Huhtala H, Pastorekova S, Pastorek J, Waheed A, et al. Carbonic anhydrase isozymes ii, IX, and XII in uterine tumors. APMIS. 2012;120:117–29.

    Article  PubMed  Google Scholar 

  20. Klatte T, Seligson DB, Rao JY, Yu H, de Martino M, Kawaoka K, et al. Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker. Cancer. 2009;115:1448–58.

    Article  PubMed  Google Scholar 

  21. Ilie M, Mazure NM, Hofman V, Ammadi RE, Ortholan C, Bonnetaud C, et al. High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer. Br J Cancer. 2010;102:1627–35.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  22. Peridis S, Pilgrim G, Athanasopoulos I, Parpounas K. Carbonic anhydrase-9 expression in head and neck cancer: a meta-analysis. European archives of oto-rhino-laryngology: official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS): affiliated with the German Society for Oto-Rhino-Laryngology -. Head Neck Surg. 2011;268:661–70.

    Google Scholar 

  23. Lin SH, Lin YM, Yeh CM, Chen CJ, Chen MW, Hung HF, et al. Casein kinase 1 epsilon expression predicts poorer prognosis in low T-stage oral cancer patients. Int J Mol Sci. 2014;15:2876–91.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Yang SF, Lee WJ, Tan P, Tang CH, Hsiao M, Hsieh FK, et al. Upregulation of mir-328 and inhibition of creb-DNA-binding activity are critical for resveratrol-mediated suppression of matrix metalloproteinase-2 and subsequent metastatic ability in human osteosarcomas. Oncotarget. 2015;6:2736–53.

    Article  PubMed  Google Scholar 

  25. Dworkin S, Simkin J, Darido C, Partridge DD, Georgy SR, Caddy J, Wilanowski T, Lieschke GJ, Doggett K, Heath JK, Jane SM. Grainyhead-like 3 regulation of endothelin-1 in the pharyngeal endoderm is critical for growth and development of the craniofacial skeleton. Mech Dev. 2014

  26. Kondo Y, Yoshikawa K, Omura Y, Shinohara A, Kazaoka Y, Sano J, et al. Clinicopathological significance of carbonic anhydrase 9, glucose transporter-1, ki-67 and p53 expression in oral squamous cell carcinoma. Oncol Rep. 2011;25:1227–33.

    PubMed  Google Scholar 

  27. Patard JJ, Fergelot P, Karakiewicz PI, Klatte T, Trinh QD, Rioux-Leclercq N, et al. Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma. Int J Cancer J Int Cancer. 2008;123:395–400.

    CAS  Article  Google Scholar 

  28. Murakami Y, Kanda K, Tsuji M, Kanayama H, Kagawa S. MN/CA9 gene expression as a potential biomarker in renal cell carcinoma. BJU Int. 1999;83:743–7.

    CAS  Article  PubMed  Google Scholar 

  29. Soyupak B, Erdogan S, Ergin M, Seydaoglu G, Kuzgunbay B, Tansug Z. Ca9 expression as a prognostic factor in renal clear cell carcinoma. Urol Int. 2005;74:68–73.

    CAS  Article  PubMed  Google Scholar 

  30. Choi SW, Kim JY, Park JY, Cha IH, Kim J, Lee S. Expression of carbonic anhydrase IX is associated with postoperative recurrence and poor prognosis in surgically treated oral squamous cell carcinoma. Hum Pathol. 2008;39:1317–22.

    CAS  Article  PubMed  Google Scholar 

  31. Perez-Sayans M, Suarez-Penaranda JM, Pilar GD, Supuran CT, Pastorekova S, Barros-Angueira F, et al. Expression of CA-IX is associated with advanced stage tumors and poor survival in oral squamous cell carcinoma patients. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol. 2012;41:667–74.

    CAS  Google Scholar 

  32. Beasley NJ, Wykoff CC, Watson PH, Leek R, Turley H, Gatter K, et al. Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density. Cancer Res. 2001;61:5262–7.

    CAS  PubMed  Google Scholar 

  33. Shin HJ, Rho SB, Jung DC, Han IO, Oh ES, Kim JY. Carbonic anhydrase IX (CA9) modulates tumor-associated cell migration and invasion. J Cell Sci. 2011;124:1077–87.

    CAS  Article  PubMed  Google Scholar 

  34. Svastova E, Pastorekova S. Carbonic anhydrase IX: a hypoxia-controlled “catalyst” of cell migration. Cell Adhes Migr. 2013;7:226–31.

    Article  Google Scholar 

  35. Chiche J, Ilc K, Laferriere J, Trottier E, Dayan F, Mazure NM, et al. Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular ph. Cancer Res. 2009;69:358–68.

    CAS  Article  PubMed  Google Scholar 

  36. Liao SY, Darcy KM, Randall LM, Tian C, Monk BJ, Burger RA, et al. Prognostic relevance of carbonic anhydrase-IX in high-risk, early-stage cervical cancer: a gynecologic oncology group study. Gynecol Oncol. 2010;116:452–8.

    CAS  Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by a research grant from the National Science Council, Taiwan (NSC96-2628-B-040-021-MY3 and NSC102-2314-B-040-008-MY3), and Chung Shan Medical University Hospital, Taiwan (CSH-2015-C-015; CSH-2015-E-001-Y2). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Conflicts of interest

None

Author information

Affiliations

  1. Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan

    Jia-Sin Yang & Shun-Fa Yang

  2. Institute of Medicine, Chung Shan Medical University, 110 Chien-Kuo N. Road, Section 1, Taichung 402, Taiwan

    Jia-Sin Yang, Shu-Hui Lin & Shun-Fa Yang

  3. Institute of Oral Sciences, Chung Shan Medical University, Taichung, Taiwan

    Chiao-Wen Lin

  4. Department of Dentistry, Chung Shan Medical University Hospital, Taichung, Taiwan

    Chiao-Wen Lin

  5. School of Medicine, Chung Shan Medical University, Taichung, Taiwan

    Chun-Yi Chuang

  6. Department of Otolaryngology, Chung Shan Medical University Hospital, Taichung, Taiwan

    Chun-Yi Chuang

  7. Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou, Taiwan

    Shih-Chi Su

  8. Whole-Genome Research Core Laboratory of Human Diseases, Chang Gung Memorial Hospital, Keelung, Taiwan

    Shih-Chi Su

  9. Department of Surgical Pathology, Changhua Christian Hospital, Changhua, Taiwan

    Shu-Hui Lin

Authors
  1. Jia-Sin Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chiao-Wen Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chun-Yi Chuang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shih-Chi Su
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shu-Hui Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shun-Fa Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shun-Fa Yang.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Yang, JS., Lin, CW., Chuang, CY. et al. Carbonic anhydrase IX overexpression regulates the migration and progression in oral squamous cell carcinoma. Tumor Biol. 36, 9517–9524 (2015). https://doi.org/10.1007/s13277-015-3692-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-015-3692-8

Keywords

  • CAIX
  • Migration
  • Tissue microarray
  • Prognosis
  • OSCC